The condensation of chlorides of substituted pyrazinecarboxylic acids with ringsubstituted anilines yielded twelve substituted pyrazinecarboxylic acid amides. The synthetic approach, analytical, and lipophilicity data of the newly synthesized compounds are presented. Two antituberculosis assays were used. Firstly, the antimycobacterial activity against four different Mycobacterium strains in a series of pyrazine derivatives was investigated. Secondly, the antimycobacterial evaluation was performed at the Tuberculosis Antimicrobial Acquisition and Coordinating Facility (TAACF) program. Interesting in vitro antimycobacterial activity was found, N-(3-iodo-4-methylphenyl) pyrazine-2-carboxamide (9) was most active derivative compound against M. tuberculosis (MIC < 2.0 micromol/L), while another iodo derivative 5-tert-butyl-6-chloro-N-(3-iodo-4-methyl-phenyl)pyrazine-2-carboxamide (12) was the most active compound in the TAACF antituberculosis screening program (IC(90) = 0.819 microg/mL).

Faculty of Pharmacy in Hradec Králové Charles University Prague Heyrovského 1203 Hradec Králové 500 05 Czech Republic

Zobrazit více v PubMed

Agrawal Y.K., Bhatt H.G., Raval H.G., Oza P.M., Vaidya H.B., Manna K., Gogoi P. Emerging trends in tuberculosis therapy—A review. J. Sci. Indust. Res. 2007;66:191–208.

Laughon B.E. New tuberculosis drugs in development. Curr. Topics Med. Chem. 2007;7:463–473. doi: 10.2174/156802607780059736. PubMed DOI

Doležal M. Biologically active pyrazines of natural and synthetic origin. Chem. Listy. 2006;100:959–966.

Speirs R.J., Welch J.T., Cynamon M.H. Activity of n-propyl pyrazinoate against pyrazinamide-resistant mycobacterium-tuberculosis: Investigation into mechanism of action and mechanism of resistence to pyrazinamide. Antimicrob. Agents Chemother. 1995;39:1269–1271. doi: 10.1128/AAC.39.6.1269. PubMed DOI PMC

Zhang Y., Wade M.M., Scorpio A., Zhang H., Sun Z.H. Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J. Antimicrob. Chemother. 2003;52:790–795. doi: 10.1093/jac/dkg446. PubMed DOI

Ngo S.C., Zimhony O., Chung W.J., Sayahi H., Jacobs W.R., Welch J.T. Inhibition of isolated mycobacterium tuberculosis fatty acid synthase I by pyrazinamide analogs. Antimicrob. Agents Chemother. 2007;51:2430–2435. doi: 10.1128/AAC.01458-06. PubMed DOI PMC

Doležal M., Hartl J., Miletín M., Macháček M., Kráľová K. Synthesis and photosynthesis-inhibiting activity of some anilides of substituted pyrazine-2-carboxylic acids. Chem. Pap. 1999;53:126–128. doi: 10.1002/chin.199946161. DOI

Doležal M., Vičík R., Miletín M., Kráľová K. Synthesis and antimycobacterial, antifungal, and photosynthesis-inhibiting evaluation of some anilides of substituted pyrazine-2-carboxylic acids. Chem. Pap. 2000;54:245–248. doi: 10.1002/chin.200104176. DOI

Doležal M., Tůmová L., Kešetovičová D., Tůma J., Kráľová K. Substituted N-phenylpyrazine-2-carboxamides, their synthesis and evaluation as herbicides and abiotic elicitors. Molecules. 2007;12:2589–2598. doi: 10.3390/12122589. PubMed DOI PMC

Doležal M., Palek L., Vinšová J., Buchta V., Jampílek J., Kráľová K. Substituted pyrazinecarboxamides; synthesis and their biological evaluation. Molecules. 2006;11:242–256. doi: 10.3390/11040242. PubMed DOI PMC

Doležal M., Čmedlová P., Palek L., Vinšová J., Kuneš J., Buchta V., Jampílek J., Kráľová K. Synthesis and antimycobacterial evaluation of substituted pyrazinecarboxamides. Eur. J. Med. Chem. 2008;43:1105–1113. doi: 10.1016/j.ejmech.2007.07.013. PubMed DOI

Ancizu S., Moreno E., Torres E., Burguete A., Pérez-Silanes S., Benítez D., Villar R., Solano B., Marín A., Aldana I., Cerecetto H., González M., Monge A. Heterocyclic-2-carboxylic acid (3-Cyano-1,4-di-N-oxidequinoxalin-2-yl)amide derivatives as hits for the development of neglected disease drugs. Molecules. 2009;14:2256–2272. doi: 10.3390/molecules14062256. PubMed DOI PMC

Cynamon M.H., Speirs R.J., Welch J.T. In vitro antimycobacterial activity of 5-chloropyrazinamide. Antimicrob Agents Chemother. 1998;42:462–463. PubMed PMC

Wade M.M., Zhang Y. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro. J. Antimicrob. Chemother. 2006;58:936–941. doi: 10.1093/jac/dkl358. PubMed DOI

Abe Y., Shigeta Y., Uchimaru F., Okada S., Ozasayama E. Methyl 6-methoxypyrazine-2-carboxylate. JP Pat. 44012898. 1969 [Chem. Abstr. 1969, 71, 112979y.]

Doležal M., Hartl J., Lyčka A., Buchta V., Odlerová Ž. Synthesis and antituberculotic properties of some substituted pyrazinecarbothioamides. Collect. Czech. Chem. Commun. 1996;61:1102–1108. doi: 10.1135/cccc19961102. DOI

[accessed 27 August, 2009];TAACF. 2009 Available online: http://www.taacf.org/Process-text.htm#nhdp-text.

Targeting Mycobacterium tuberculosis: The Role of Alkyl Substitution in Pyrazinamide Derivatives

Synthesis and In Vitro Antimycobacterial Activity of Novel N-Arylpiperazines Containing an Ethane-1,2-diyl Connecting Chain

Design, Synthesis, Antimycobacterial Evaluation, and In Silico Studies of 3-(Phenylcarbamoyl)-pyrazine-2-carboxylic Acids

Novel pyrazine analogs of chalcones: synthesis and evaluation of their antifungal and antimycobacterial activity

Pyrazinecarboxamides as potential elicitors of flavonolignan and flavonoid production in Silybum marianum and Ononis arvensis cultures in vitro

Synthesis, antimycobacterial, antifungal and photosynthesis-inhibiting activity of chlorinated N-phenylpyrazine-2-carboxamides

Substituted pyrazinecarboxamides as abiotic elicitors of flavolignan production in Silybum marianum (L.) gaertn cultures in vitro